期刊文献+

热疗联合胸腔内化疗治疗恶性胸腔积液的临床研究 被引量:8

Clinical study of hyperthermia combined with intra-pleural chemotherapy in the treatment of malignant pleural effusion
下载PDF
导出
摘要 目的观察热疗联合胸腔内化疗治疗癌性胸腔积液的疗效。方法 63例确诊为癌性胸腔积液患者随机分两组:对照组31例接受中心静脉置管抽液后单纯胸腔内灌注化疗药物;研究组32例给予置管抽液后灌注化疗药物治疗及热疗。比较两组患者的临床症状改善状况、生活质量及不良反应。结果研究组胸水治疗有效率明显高于对照组(87.5%vs 64.5%,P<0.05),生活质量的改善率亦明显好于对照组(93.8%vs66.7%,P<0.01)。两组毒性反应率比较无统计学差异(P>0.05)。结论热疗及胸腔灌注化疗联合治疗癌性胸腔积液的疗效显著,不良反应未增加。 Objective To study the curative effect of hyperthermia combined with intra-pleural chemotherapy in the treatment of malignant pleural effusion. Methods 63 with malignant pleural effusion were randomly divided into two groups. The control group (31 cases) received central venous drainage with chest internal chemotherapeutic drugs. The study group (32 cases) was treated with intra-pleural catheter drainage after chemotherapy combined with hyperthermia. The clinical symptoms, the improvement of quality and adverse reactions were compared between the two groups. Results The effective rate was higher in the study group than in the control group. The quality of life was significantly better in the study group than in the control group. The toxicity of the two groups had no statistical difference. Conclusion Hyperthermia and pleural infusion combined with chemotherapy has significantly curative effect in the treatment of malignant pleural effusions, with less adverse reactions.
出处 《临床肺科杂志》 2015年第1期108-110,共3页 Journal of Clinical Pulmonary Medicine
关键词 热疗 恶性胸腔积液 腔内化疗 hyperthermia malignant pleural effusion intra-eavitary chemotherapy
  • 相关文献

参考文献8

二级参考文献46

  • 1夏冬,祝胜美,章岳山,冯智英.在晚期肿瘤患者红外线全身热疗联合化疗中冬眠1号-东莨菪碱镇静的可行性[J].中华麻醉学杂志,2004,24(11):868-869. 被引量:6
  • 2王立伟,焦顺昌.恶性胸腔积液的综合治疗新进展[J].中国肿瘤临床,2006,33(4):236-239. 被引量:102
  • 3Westermann AM,Gosen EA,Katschinski DM,et al.A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer[J].European Journal of Cancer,2001,37:1111-1117.
  • 4Tanackovic D,Hegewisch BS,Faltz C,et al.Whole body hyperthermia induces expression of the activation antigen CD69 on peripheral lymphocytes of cancer patients[J].Blood,2000,96:619.
  • 5Katschinski DM,Wiedemann GJ,Longo W,et al.Whole body hyperthermia cytokine induction:a review and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy[J].Cytokine Growth Factor Rev,1999,10:93-97.
  • 6Negoro S,Masuda N,Takada Y,et al.Randomised phase Ⅲ trial of irinotecan combined with cisplatin for advanced non small cell lung cancer[J].Br J Cancer,2003,88(3):335-341.
  • 7Zwischenberger JB,Vertrees RA,Woodson LC,et al.Percutanerous venovenous perfusion-induced systemic hyperthermia for advanced non-small cell lung cancer:initial clinical exerience[J].Ann Thorac Surg,2001,72(1):234-242.
  • 8Paccagnella A,Oniga F,Bearz A,et al.Adding gemcitabine to paclitaxel / carbop latin combination increases surbvival in advanced non-small cell lung cancer results of a phase Ⅱ-Ⅲ study[J].J Clin Oncol,2006,24 (14):2220.
  • 9F Fang, P Chen, X Wu,et al. Therapeutic effeets of recombinanl human endostatin adenovirus in a mouse model of malignant pleural effusion[ J ].Cancer Res Clin Oneol, September I, 2009, 135 ( 9 ) : 1149 - 57.
  • 10Pichelmayer O, Gruenberger B, Zielinski C, et al. Bevacizumab is active in malignant eftusion [ J ]. Ann Oncol, 2006,17 ( 12 ) : 1853.

共引文献37

同被引文献82

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部